Generative AI for Drug Discovery NYC #TechWeek
Join us at BioLabs@NYU for an enlightening panel and networking session focused on the groundbreaking intersection of deep learning, generative AI, and medicine. This event will bring together leading experts in the fields of machine learning and drug discovery with VCs to explore how recent advances in technology can be harnessed to develop new treatments for diseases. This is a unique opportunity for researchers, practitioners, and anyone interested in the future of healthcare and technology to gain insights into how AI is transforming the landscape of drug discovery.
Agenda:
Welcome and Introductions
Panel Discussion: Leveraging Generative AI for Drug Discovery
Yin He, Healthcare & Life Science AWS
Hamdi Cavusoglu, Merck Digital Sciences Studio
Gabriella Garcia, Felicis
Luca Naef, Vant AI
Aliya J. Sanders, Gunderson Dettmer
Rayees Rahman, Harmonic Discovery
Bogdan Knezevic, Kaleidoscope Bio
Audience Q&A
Networking and Close
This event is a part of #TechWeek - a week of events hosted by VCs and startups to bring together the tech ecosystem.
Hosted by Harmonic Discovery, Kaleidoscope Bio, BioLabs@NYU, AWS, and Gunderson Dettmer.
Harmonic Discovery is a biotechnology startup that builds advanced machine learning and generative AI to design drugs that embrace the complexity of disease. Our mission is to create best-in-class drugs with precision pharmacology—molecules that target specific proteins linked to efficacy while minimizing off-target interactions that drive toxicity. Founded in 2021, Harmonic Discovery has raised $8M from leading VCs such as Innovation Endeavors, Fifty Years, and Y Combinator.
Kaleidoscope Bio is a software company building infrastructure for tracking and communicating mission-critical R&D data. With Kaleidoscope, biotech companies can build interactive dashboards and dynamic data rooms to both drive internal projects forward as well as align + collaborate externally. The Kaleidoscope platform connects directly into a company's existing stack, giving teams a powerful project management framework that is synced with all relevant sources of R&D data.
BioLabs@NYU is a biotech co-working facility in SoHo that supports companies in early-stage life sciences. They provide an engaging, collaborative space, top-of-the-line research equipment, business support and acceleration programming to help startup companies reach their milestones faster.
AWS Healthcare and Life Sciences Startups Team provides dedicated resources, expertise, and support to help high-potential healthcare and life sciences startups excel and grow. We are a team of former scientists and physicians turned founders/operators/investors, that help match AWS/Amazon capabilities to the needs of startups, and help them build for scale, overcome technical and regulatory challenges, and accelerate time to market. We invest credits, people, time, technology, experience, and best practices in an effort to remove obstacles and open doors for our startups.
Gunderson Dettmer is the preeminent international law firm with an exclusive focus on the innovation economy. They represent healthcare, digital health and life sciences clients headquartered around the world – from founders who are spinning intellectual property out of universities to venture-backed and public companies, as well as venture capital and growth equity firms focused on investing in those industries. Gunderson's Life Sciences and Corporate lawyers work with companies and investors innovating in every segment of the life sciences space, including medical devices, tools, diagnostics, therapeutics, and healthcare IT.